Basophils help establish protective immunity induced by irradiated larval vaccination for filariasis

Vaccine

Volumn 31, Issue 36, 2013, Pages 3675-3682

  Torrero, Marina N ^a   Morris, C Paul ^a   Mitre, Blima K ^b   Hübner, Marc P ^c   Fox, Ellen M ^a   Karasuyama, Hajime ^d   Mitre, Edward ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b PA 1 Disaster Medical Assistance Team   (United States)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Basophil; Filariasis; Helminth; Litomosoides sigmodontis; Type 2 immunity; Vaccine

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; BASOPHIL; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; FILARIASIS; IMMUNE RESPONSE; IMMUNITY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PLEURA CAVITY; PRIORITY JOURNAL; VACCINATION;

BASOPHIL; FILARIASIS; HELMINTH; LITOMOSOIDES SIGMODONTIS; TYPE 2 IMMUNITY; VACCINE;

ANIMALS; ANTIBODIES, HELMINTH; ANTIBODIES, MONOCLONAL; BASOPHILS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FILARIASIS; FILARIOIDEA; IMMUNITY, CELLULAR; IMMUNOGLOBULIN E; INTERFERON-GAMMA; INTERLEUKINS; LARVA; LYMPHOCYTE DEPLETION; MAST CELLS; MICE; MICE, INBRED BALB C; VACCINES;

EID: 84880959519     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.010     Document Type: Article

References (40)

1. WHO Global programme to eliminate lymphatic filariasis: progress report, 2011. Wkly Epidemiol Rec 2012, 87:346-356.
2. WHO Onchocerciasis - the disease and its impact 2012, African Programme for Onchocerciasis Control, Available from:, [cited 05.03.13]. http://www.who.int/apoc/onchocerciasis/disease/en/index.html.
3. Babayan S.A., Allen J.E., Taylor D.W. Future prospects and challenges of vaccines against filariasis. Parasite Immunol 2012, 34(5):243-253.
4. Wong M.M., Fredericks H.J., Ramachandran C.P. Studies on immunization against Brugia malayi infection in the rhesus monkey. Bull World Health Organ 1969, 40(4):493-501.
5. Le Goff L., Marechal P., Petit G., Taylor D.W., Hoffmann W., Bain O. Early reduction of the challenge recovery rate following immunization with irradiated infective larvae in a filaria mouse system. Trop Med Int Health 1997, 2(12):1170-1174.
6. Lucius R., Textor G., Kern A., Kirsten C. Acanthocheilonema viteae: vaccination of jirds with irradiation-attenuated stage-3 larvae and with exported larval antigens. Exp Parasitol 1991, 73(2):184-196.
7. Oothuman P., Denham D.A., McGreevy P.B., Nelson G.S., Rogers R. Successful vaccination of cats against Brugia pahangi with larvae attenuated by irradiation with 10 krad cobalt 60. Parasite Immunol 1979, 1(3):209-216.
8. Schrempf-Eppstein B., Kern A., Textor G., Lucius R. Acanthocheilonema viteae: vaccination with irradiated L3 induces resistance in three species of rodents (Meriones unguiculatus, Mastomys coucha, Mesocricetus auratus). Trop Med Int Health 1997, 2(1):104-110.
9. Yates J.A., Higashi G.I. Brugia malayi: vaccination of jirds with 60 cobalt-attenuated infective stage larvae protects against homologous challenge. Am J Trop Med Hyg 1985, 34(6):1132-1137.
10. Yoshida M., Nakagaki K., Nogami S., Harasawa R., Maeda R., Katae H., et al. Immunologic protection against canine heartworm infection. J Vet Med Sci 1997, 59(12):1115-1121.
11. Hubner M.P., Torrero M.N., Mitre E. Type 2 immune-inducing helminth vaccination maintains protective efficacy in the setting of repeated parasite exposures. Vaccine 2010, 28(7):1746-1757.
12. Le Goff L., Martin C., Oswald I.P., Vuong P.N., Petit G., Ungeheuer M.N., et al. Parasitology and immunology of mice vaccinated with irradiated Litomosoides sigmodontis larvae. Parasitology 2000, 120(Pt 3):271-280.
13. Taylor M.J., van Es R.P., Shay K., Folkard S.G., Townson S., Bianco A.E. Protective immunity against Onchocerca volvulus and O. lienalis infective larvae in mice. Trop Med Parasitol 1994, 45(1):17-23.
14. Karasuyama H., Wada T., Yoshikawa S., Obata K. Emerging roles of basophils in protective immunity against parasites. Trends Immunol 2011, 32(3):125-130.
15. Leon-Cabrera S., Flisser A. Are basophils important mediators for helminth-induced th2 immune responses? A debate. J Biomed Biotechnol 2012, 2012(20):274150.
16. Voehringer D. Basophils in immune responses against helminths. Microbes Infect 2011, 13(11):881-887.
17. Mitre E., Nutman T.B. Basophils, basophilia and helminth infections. Chem Immunol Allergy 2006, 90:141-156.
18. Oh K., Shen T., Le Gros G., Min B. Induction of Th2 type immunity in a mouse system reveals a novel immunoregulatory role of basophils. Blood 2007, 109(7):2921-2927.
19. Gauchat J.F., Henchoz S., Mazzei G., Aubry J.P., Brunner T., Blasey H., et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993, 365(6444):340-343.
20. Siracusa M.C., Saenz S.A., Hill D.A., Kim B.S., Headley M.B., Doering T.A., et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 2011, 14(10).
21. Li H., Sim T.C., Alam R. IL-13 released by and localized in human basophils. J Immunol 1996, 156(12):4833-4838.
22. Mitre E., Taylor R.T., Kubofcik J., Nutman T.B. Parasite antigen-driven basophils are a major source of IL-4 in human filarial infections. J Immunol 2004, 172(4):2439-2445.
23. Torrero M.N., Hubner M.P., Larson D., Karasuyama H., Mitre E. Basophils amplify type 2 immune responses, but do not serve a protective role, during chronic infection of mice with the filarial nematode Litomosoides sigmodontis. J Immunol 2010, 185(12):7426-7434.
24. Siracusa M.C., Comeau M.R., Artis D. New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation. Ann N Y Acad Sci 2011, 1217:166-177.
25. Ohnmacht C., Voehringer D. Basophils protect against reinfection with hookworms independently of mast cells and memory Th2 cells. J Immunol 2010, 184(1):344-350.
26. Hoffmann W., Petit G., Schulz-Key H., Taylor D., Bain O., Le Goff L. Litomosoides sigmodontis in mice: reappraisal of an old model for filarial research. Parasitol Today 2000, 16(9):387-389.
27. Hubner M.P., Torrero M.N., McCall J.W., Mitre E. Litomosoides sigmodontis: a simple method to infect mice with L3 larvae obtained from the pleural space of recently infected jirds (Meriones unguiculatus). Exp Parasitol 2009, 123(1):95-98.
28. Obata K., Mukai K., Tsujimura Y., Ishiwata K., Kawano Y., Minegishi Y., et al. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 2007, 110(3):913-920.
29. Martin C., Saeftel M., Vuong P.N., Babayan S., Fischer K., Bain O., et al. B-cell deficiency suppresses vaccine-induced protection against murine filariasis but does not increase the recovery rate for primary infection. Infect Immun 2001, 69(11):7067-7073.
30. Newlands G.F., Miller H.R., MacKellar A., Galli S.J. Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N. brasiliensis infection. Blood 1995, 86(5):1968-1976.
31. Grencis R.K., Else K.J., Huntley J.F., Nishikawa S.I. The in vivo role of stem cell factor (c-kit ligand) on mastocytosis and host protective immunity to the intestinal nematode Trichinella spiralis in mice. Parasite Immunol 1993, 15(1):55-59.
32. Anthony R.M., Rutitzky L.I., Urban J.F., Stadecker M.J., Gause W.C. Protective immune mechanisms in helminth infection. Nat Rev Immunol 2007, 7(12):975-987.
33. Le Goff L., Lamb T.J., Graham A.L., Harcus Y., Allen J.E. IL-4 is required to prevent filarial nematode development in resistant but not susceptible strains of mice. Int J Parasitol 2002, 32(10):1277-1284.
34. Volkmann L., Bain O., Saeftel M., Specht S., Fischer K., Brombacher F., et al. Murine filariasis: interleukin 4 and interleukin 5 lead to containment of different worm developmental stages. Med Microbiol Immunol (Berl) 2003, 192(1):23-31.
35. Martin C., Al-Qaoud K.M., Ungeheuer M.N., Paehle K., Vuong P.N., Bain O., et al. IL-5 is essential for vaccine-induced protection and for resolution of primary infection in murine filariasis. Med Microbiol Immunol 2000, 189(2):67-74.
36. Le Goff L., Loke P., Ali H.F., Taylor D.W., Allen J.E. Interleukin-5 is essential for vaccine-mediated immunity but not innate resistance to a filarial parasite. Infect Immun 2000, 68(5):2513-2517.
37. Martin C., Le Goff L., Ungeheuer M.N., Vuong P.N., Bain O. Drastic reduction of a filarial infection in eosinophilic interleukin-5 transgenic mice. Infect Immun 2000, 68(6):3651-3656.
38. Specht S., Frank J.K., Alferink J., Dubben B., Layland L.E., Denece G., et al. CCL17 controls mast cells for the defense against filarial larval entry. J Immunol 2011, 186(8):4845-4852.
39. Babayan S., Ungeheuer M.N., Martin C., Attout T., Belnoue E., Snounou G., et al. Resistance and susceptibility to filarial infection with Litomosoides sigmodontis are associated with early differences in parasite development and in localized immune reactions. Infect Immun 2003, 71(12):6820-6829.
40. Saeftel M., Volkmann L., Korten S., Brattig N., Al-Qaoud K., Fleischer B., et al. Lack of interferon-gamma confers impaired neutrophil granulocyte function and imparts prolonged survival of adult filarial worms in murine filariasis. Microbes Infect 2001, 3(3):203-213.